phosphatidylcholines has been researched along with Carcinoma, Lewis Lung in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Baskaev, KK; Korotkevich, EI; Kudinov, VA; Morozevich, GE; Sanzhakov, MA; Stepanova, DS; Tereshkina, YA; Tikhonova, EG; Torkhovskaya, TI | 1 |
| He, Y; Su, Z; Xu, H; Xue, L; Zhang, C | 1 |
| Hartner, WC; Kale, A; Ko, YT; Papahadjopoulos-Sternberg, B; Torchilin, VP | 1 |
| Ishida, T; Kiwada, H; Matsunaga, M; Moriyoshi, N; Nakamura, K; Suzuki, T; Tagami, T | 1 |
| Bally, MB; Cullis, PR; Harasym, TO | 1 |
| Krishna, R; Mayer, LD; St Onge, G; Webb, MS | 1 |
6 other study(ies) available for phosphatidylcholines and Carcinoma, Lewis Lung
| Article | Year |
|---|---|
Composite phospholipid-gold nanoparticles with targeted fragment for tumor imaging.
Topics: Animals; Carcinoma, Lewis Lung; Drug Delivery Systems; Dynamic Light Scattering; Folate Receptors, GPI-Anchored; Folic Acid; Glycine max; Gold; HeLa Cells; Humans; Ligands; Male; Metal Nanoparticles; Mice; Particle Size; Phosphatidylcholines; Phospholipids; Surface Plasmon Resonance | 2021 |
Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.
Topics: A549 Cells; Animals; Antineoplastic Agents; Apoptosis; Benzoates; Carcinoma, Lewis Lung; Cell Survival; Doxorubicin; Drug Carriers; Drug Liberation; Drug Synergism; Drug Therapy, Combination; Erlotinib Hydrochloride; Humans; Hydrogen-Ion Concentration; Male; Mice, Inbred C57BL; Nanoparticles; Phosphatidylcholines; Protein Kinase Inhibitors; Rats, Sprague-Dawley | 2016 |
Self-assembling micelle-like nanoparticles based on phospholipid-polyethyleneimine conjugates for systemic gene delivery.
Topics: Animals; Carcinoma, Lewis Lung; Cell Line, Tumor; Cell Survival; DNA; Gene Expression; Gene Transfer Techniques; Green Fluorescent Proteins; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Micelles; Microscopy, Electron; Microscopy, Fluorescence; Nanoparticles; NIH 3T3 Cells; Particle Size; Phosphatidylcholines; Phospholipids; Phosphorylcholine; Plasmids; Polyethyleneimine; Tissue Distribution; Transfection | 2009 |
Anti-angiogenic therapy via cationic liposome-mediated systemic siRNA delivery.
Topics: Air Sacs; Animals; Argonaute Proteins; Carcinoma, Lewis Lung; Cations; Cell Cycle Checkpoints; Cell Proliferation; Cholesterol; Ethanolamines; Genetic Therapy; Lipids; Liposomes; Male; Mice; Myristates; Neovascularization, Pathologic; Neovascularization, Physiologic; Phosphatidylcholines; Phosphatidylethanolamines; Polyethylene Glycols; RNA Interference; RNA, Small Interfering; Time Factors; Transfection; Tumor Burden | 2012 |
Intratumor distribution of doxorubicin following i.v. administration of drug encapsulated in egg phosphatidylcholine/cholesterol liposomes.
Topics: Animals; Antibiotics, Antineoplastic; Carcinoma, Lewis Lung; Cholesterol; Doxorubicin; Drug Carriers; Drug Delivery Systems; Female; Fluorescent Antibody Technique, Indirect; Injections, Intravenous; Leukemia L1210; Liposomes; Macrophage-1 Antigen; Melanoma, Experimental; Mice; Phosphatidylcholines; Tissue Distribution | 1997 |
Liposomal and nonliposomal drug pharmacokinetics after administration of liposome-encapsulated vincristine and their contribution to drug tissue distribution properties.
Topics: Animals; Antineoplastic Agents, Phytogenic; Area Under Curve; Carcinoma, Lewis Lung; Cholesterol; Drug Carriers; Female; Injections, Intravenous; Liposomes; Mice; Phosphatidylcholines; Sphingomyelins; Tissue Distribution; Vincristine | 2001 |